系统性硬化症相关的间歇性肺病患者强迫生命能力的轨迹
Oliver Distler1, Madelon C Vonk2, Arata Azuma3,4
1Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Oliver.Distler@usz.ch.
Arthritis research & therapy
|March 22, 2025
概括
长期的宁泰达尼布治疗减缓了系统性硬化症相关的间歇性肺病 (SSc-ILD) 的肺功能下降. 在SSc-ILD患者中,从安慰剂转换为nintedanib也对强迫生命能力 (FVC) 进展产生了有益影响.
科学领域:
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
- 临床药理学 临床药理学
背景情况:
- 系统性硬化症相关的间歇性肺病 (SSc-ILD) 是一种具有显著发病率的渐进性疾病.
- 强迫生命能力 (FVC) 的下降是SSc-ILD疾病进展和预后的关键指标.
- 丁丁达尼布是SSc-ILD的批准治疗方法,但长期疗效和从安慰剂转换的影响需要进一步评估.
研究的目的:
- 评估宁泰达尼布对SSc-ILD患者FVC衰退的长期影响.
- 评估从安慰剂转换为宁泰达尼布对肺功能轨迹的影响.
- 分析继续服用宁泰丹尼布的患者和在安慰剂暴露后开始服用宁泰丹尼布的患者的FVC变化.
主要方法:
- 来自SENSCIS和SENSCIS-ON临床试验的数据分析.
- 在接受连续宁泰达尼布治疗的患者中评估FVC下降.
- 在从安慰剂转换为任天达尼布的患者中评估FVC变化.
- 使用的定测量:SENSCIS中的最后一次处理FVC和SENSCIS-ON.中的基线FVC.
主要成果:
- 连续服用宁泰达尼布的患者在52周内,SENSCIS的FVC平均下降为-41.5mL,SENSCIS-ON的FVC平均下降为-58.3mL.
- 从安慰剂转换为宁泰达尼布的患者在52周内,SENSCIS (安慰剂) 的FVC平均下降为-96.8毫升,SENSCIS-ON (宁泰达尼布) 的FVC平均下降为-42.8毫升.
- 这些结果表明,当患者接受nintedanib时,FVC下降的速度较慢.
结论:
- 在长期内,丁丁达尼布在减缓SSc-ILD肺功能下降方面表现出持续的有效性.
- 即使在服用安慰剂后,也可以启动宁泰达尼布治疗,以减轻FVC逐渐下降的情况.
- 这些发现支持长期使用宁泰达尼布来管理SSc-ILD并保持肺功能.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Lung Capacity
48.9K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
48.9K
COPD: Pathogenesis and Clinical Features
219
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
219
Pulmonary Function Tests
282
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
282
Respiratory Volumes and Capacities I
796
Assessing the respiratory rate and rhythm for a complete minute is crucial for evaluating the breathing pattern. Even a minor increase in the patient's average respiratory rate, by as little as three to five breaths per minute, is an early and vital indicator of respiratory distress. Patients with a respiratory rate exceeding twenty-four breaths per minute require close monitoring to determine the physiological alterations. This careful observation is essential for prompt recognition and...
796


